Core Insights - The article highlights the positive performance of equity funds in the second half of the year, with many fund managers showcasing their personal investment gains, leading to increased investor interest [1][2]. Fund Manager Performance - Over 20 public fund managers have shared their real-time investment data, with most reporting profits; the highest cumulative gain exceeds 1.04 million yuan [1][3]. - Notable fund managers include Yao Jiahong from Guojin Fund, whose total investment amount reached 4.05 million yuan with a cumulative profit of 1.048 million yuan [3][4][5]. - Other fund managers, such as Ma Fang from Guojin Fund, reported a total investment of 1.9422 million yuan with a cumulative profit of 587,000 yuan [5]. Investment Strategies - Fund managers suggest employing a contrarian approach during market adjustments, advocating for strategies like dollar-cost averaging and profit-taking at highs [1][12]. - The innovative drug sector is highlighted as a promising investment area, with expectations of continued growth driven by policy support and market demand [12]. Market Conditions - The article notes that despite some funds still being in a loss position, many have achieved significant gains in the recent market rally [7][9]. - The overall market environment remains favorable for small-cap growth stocks, with ample liquidity present [13].